CompletedEarly Phase 1NCT05105087
Gynecological Sentinel Lymph Nodes CEUS
Studying Vaginal carcinoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Thomas Jefferson University
- Principal Investigator
- Ji-Bin Liu, MD, M.DThomas Jefferson University
- Intervention
- Perflubutane Microbubble(drug)
- Enrollment
- 9 enrolled
- Eligibility
- 18 years · FEMALE
- Timeline
- 2022 – 2025
Study locations (1)
- Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05105087 on ClinicalTrials.govOther trials for Vaginal carcinoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07407647Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal CancerOhio State University Comprehensive Cancer Center
- RECRUITINGPHASE2NCT06686043HPV Vaccine, Imiquimod, and Metformin Combination TrialBaylor College of Medicine
- ACTIVE NOT RECRUITINGNCT04713618Changes in Pelvic Health, Sexual Function, and Quality of Life in Women With Pelvic Cancer Undergoing Radiation TherapyOhio State University Comprehensive Cancer Center
- ACTIVE NOT RECRUITINGNCT00791635Longitudinal Evaluation of Women Undergoing Pelvic Surgery for the Treatment of Gynecologic CancerM.D. Anderson Cancer Center